Glenmark Life Sciences Limited
NSE:GLS.NS
1096.1 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 3,014.14 | 2,838.23 | 5,121.57 | 1,155.96 | 99.98 | 20.61 | 0.07 |
| Short Term Investments
| 905.48 | 964.78 | 51.46 | 241.64 | 207.7 | 57.87 | 0 |
| Cash and Short Term Investments
| 3,919.62 | 3,803.01 | 5,173.03 | 1,397.6 | 307.68 | 78.48 | 0.07 |
| Net Receivables
| 7,654.32 | 8,067.66 | 6,742.53 | 7,510.04 | 7,281.03 | 5,233.4 | 0.31 |
| Inventory
| 6,665.91 | 6,041.71 | 5,162.44 | 5,134.21 | 4,127.75 | 4,008.43 | 0.38 |
| Other Current Assets
| 920.14 | 591.01 | 567.84 | 7,458.6 | 7,165.71 | 5,220.05 | 0.08 |
| Total Current Assets
| 19,159.99 | 18,503.39 | 17,645.84 | 13,990.41 | 11,601.14 | 9,306.96 | 0.84 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 8,961.97 | 8,242.44 | 6,763.36 | 5,789.86 | 5,498.08 | 5,303 | 0.01 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 148.53 | 180.01 | 103.8 | 79.11 | 71.68 | 63.51 | 0 |
| Goodwill and Intangible Assets
| 148.53 | 180.01 | 103.8 | 79.11 | 71.68 | 63.51 | 0 |
| Long Term Investments
| -794.41 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0 |
| Tax Assets
| 942.2 | 82.14 | 55.6 | 20.26 | 1.31 | 79.23 | 0 |
| Other Non-Current Assets
| 85.84 | 12.72 | 140.7 | 90.34 | 83.06 | 0.48 | -0.01 |
| Total Non-Current Assets
| 9,344.13 | 8,518.08 | 7,064.23 | 5,980.34 | 5,654.9 | 5,446.99 | 0.01 |
| Total Assets
| 28,504.12 | 27,021.47 | 24,710.07 | 19,970.75 | 17,256.04 | 14,753.95 | 0.85 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 3,686.61 | 3,965.61 | 3,244.04 | 2,225.95 | 2,034.67 | 1,873.93 | 0.13 |
| Short Term Debt
| 23.87 | 22.65 | 16.8 | -72.9 | 0.21 | 0.21 | 14.5 |
| Tax Payables
| 0 | 70.78 | 120.03 | 136.93 | 83.6 | 23.54 | 0 |
| Deferred Revenue
| 523.02 | 759.12 | 545.11 | 72.9 | -24.17 | -45.26 | -14.5 |
| Other Current Liabilities
| 154.23 | 296.76 | 34.01 | 9,988.45 | 11,063.93 | 11,975.26 | 14.7 |
| Total Current Liabilities
| 4,387.73 | 5,044.14 | 3,839.96 | 12,214.4 | 13,074.64 | 13,804.14 | 14.83 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 147.61 | 170.92 | 12.04 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | -424.34 | -314.95 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 487.85 | 424.34 | 314.95 | 228.88 | 164.48 | 68.56 | 0 |
| Other Non-Current Liabilities
| 157.71 | 424.34 | 314.95 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 793.17 | 595.26 | 326.99 | 228.88 | 164.48 | 68.56 | 0 |
| Total Liabilities
| 5,180.9 | 5,639.4 | 4,166.95 | 12,443.28 | 13,239.12 | 13,872.7 | 14.83 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 13.98 |
| Common Stock
| 245.05 | 245.05 | 245.05 | 19.6 | 19.6 | 19.6 | 0.1 |
| Retained Earnings
| 12,918.03 | 11,020.63 | 10,213.53 | 7,507.87 | 3,997.32 | 861.65 | -14.08 |
| Accumulated Other Comprehensive Income/Loss
| 23,078.17 | 66.83 | 34.98 | 7,507.87 | 3,997.32 | 861.65 | -14.08 |
| Other Total Stockholders Equity
| -12,918.03 | 10,049.56 | 10,049.56 | -7,507.87 | -3,997.32 | -861.65 | 0.1 |
| Total Shareholders Equity
| 23,323.22 | 21,382.07 | 20,543.12 | 7,527.47 | 4,016.92 | 881.25 | -13.98 |
| Total Equity
| 23,323.22 | 21,382.07 | 20,543.12 | 7,527.47 | 4,016.92 | 881.25 | -13.98 |
| Total Liabilities & Shareholders Equity
| 28,504.12 | 27,021.47 | 24,710.07 | 19,970.75 | 17,256.04 | 14,753.95 | 0.85 |